Interestingly, the SM-AHNMD sub-group co-expressed a combination of more than one genetic and/or epigenetic mutation (e.g. KIT D816V / TET2 / DNMT3A or TET2 / DNMT3A or TET2 / ASLXL1). This evidence concerns the gene KIT and systemic mastocytosis.